Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -29.49EBIT per Share
VS
Market
Sector
Industry
History
$ 14.15Close
$ 6.7 - $ 682.84 52-Week Range
Ticker Information
Ticker
RNAZCompany Name
TRANSCODE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTRANSCODE THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RNAZ - EBITPS Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -24.59M | $ -29.49 | 1 | 833.65K |
| 3/31/2025 | $ -25.5M | $ -148.01 | 1 | 172.26K |
| 12/31/2024 | $ -16.73M | $ -1.32K | 1 | 12.72K |
| 9/30/2024 | $ -14.85M | $ -934.1 | 1 | 15.89K |
| 6/30/2024 | $ -17.84M | $ -2.34K | 1 | 7.63K |
| 3/31/2024 | $ -16.99M | $ -3.05K | 1 | 5.57K |
| 12/31/2023 | $ -18.49M | $ -95.31K | 1 | 194 |
| 9/30/2023 | $ -19.59M | $ -230.5K | 1 | 85 |
| 6/30/2023 | $ -18.58M | $ -516.17K | 1 | 36 |
| 3/31/2023 | $ -18.91M | $ -995.36K | 1 | 19 |
Key Performance Insights, Last 5 Years
- TRANSCODE THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -324.89K.
- Over the past 5 years, TRANSCODE THERAPEUTICS INC's average EBITPS has been $ -354.01K.
- The median EBITPS for TRANSCODE THERAPEUTICS INC during this period was $ -275.97K
- TRANSCODE THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ -29.49.
- The lowest EBITPS recorded by TRANSCODE THERAPEUTICS INC in the same timeframe $ -995.36K
Similar metrics to Shares WA:
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBIT per Share
[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for TRANSCODE THERAPEUTICS INC is calculated as follows: EBIT [ $ -1.95M ] / (Shares WA [ 6 ] * Share Factor [ 1 ])
(=) EBITPS [ $ -324.89K ] RNAZ - EBIT per Share, Last 5 years
$ -995.36K
Minimum
Mar 31, 2023
$ -29.49
Maximum
Jun 30, 2025
$ -354.01K
Average
$ -275.97K
Median
EBITPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.17 with a standard deviation of $ 3.44.
The following table provides additional summary stats:
EBITPS in the Market:
| filtered constituents | 3.8K |
|---|---|
| min | $ -9.77 |
| max | $ 10.86 |
| average | $ 1.17 |
| median | $ 0.39 |
| std | $ 3.44 |